# Glycemic Control and Variability for Congestive Heart Failure Exacerbation

> **NCT00812487** · PHASE1,PHASE2 · COMPLETED · sponsor: **Kathleen Dungan** · enrollment: 75 (actual)

## Conditions studied

- Congestive Heart Failure
- Diabetes Mellitus

## Interventions

- **DRUG:** Intravenous insulin
- **DRUG:** Subcutaneous insulin

## Key facts

- **NCT ID:** NCT00812487
- **Lead sponsor:** Kathleen Dungan
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2012-08
- **Final completion:** 2013-09
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2013-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00812487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00812487, "Glycemic Control and Variability for Congestive Heart Failure Exacerbation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00812487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*